Construction and characterization of a Vibrio cholerae serogroup O139 vaccine candidate by genetic engineering

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2239-2244

  Cheng, Cancan ^a   Zhou, Yanyan ^a   Kan, Biao ^b   Wang, Qian ^a   Rui, Yongyu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Attenuated live vaccine; Homologous recombination; O139 Vibrio cholerae

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; LIVE ATTENUATED VIBRIO CHOLERAE SEROGROUP O139 VACCINE; PLASMID DNA; UNCLASSIFIED DRUG; DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CTX BACTERIAL GENE; CTXB BACTERIAL GENE; CYTOTOXICITY; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE TRANSFER; GENETIC ENGINEERING; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; RSTR BACTERIAL GENE; RTX BACTERIAL GENE; TLC BACTERIAL GENE; VIBRIO CHOLERAE; ANIMAL; CHOLERA; GENE VECTOR; GENETICS; ILEUM; IMMUNOLOGY; PATHOLOGY; RABBIT; TOXICITY;

ANIMALS; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC VECTORS; ILEUM; RABBITS; VACCINES, DNA; VIBRIO CHOLERAE O139;

EID: 84899704672     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2065     Document Type: Article

References (22)

1. Harris JB, LaRocque RC, Qadri F, et al: Cholera. Lancet 379: 2466-2476, 2012.
2. Leung DT, Chowdhury F, Calderwood SB, et al: Immune responses to cholera in children. Expert Rev Anti Infect Ther 10: 435-444, 2012.
3. Harris AM, Bhuiyan MS, Chowdhury F, et al: Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun 77: 3850-3856, 2009.
4. Qadri F1, Chowdhury MI, Faruque SM, et al: Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine 25: 231-238, 2007.
5. Trach DD, Cam PD, Ke NT, et al: Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam. Bull World Health Organ 80: 2-8, 2002. (Pubitemid 34151502)
6. Davis BM, Moyer KE, Boyd EF and Waldor MK: CTX prophages in classical biotype Vibrio cholerae: functional phage genes but dysfunctional phage genomes. J Bacteriol 182: 6992-6998, 2000. (Pubitemid 32266049)
7. Simon R, Priefer U and Pühler A: A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Nat Biotechnol 1: 784-791, 1983. (Pubitemid 14239484)
8. Philippe N, Alcaraz JP, Coursange E, Geiselmann J and Schneider D: Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid 51: 246-255, 2004. (Pubitemid 38510371)
9. Lin W, Fullner KJ, Clayton R, et al: Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci USA 96: 1071-1076, 1999. (Pubitemid 29072185)
10. Smithies O, Gregg RG, Boggs SS, et al: Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317: 230-234, 1985. (Pubitemid 16246494)
11. Fullner KJ and Mekalanos JJ: In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J 19: 5315-5323, 2000.
12. Boardman BK, Meehan BM and Fullner Satchell KJ: Growth phase regulation of Vibrio cholerae RTX toxin export. J Bacteriol 189: 1827-1835, 2007. (Pubitemid 46446145)
13. Karaolis DK, Somara S, Manevel DR Jr, et al: A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature 399: 375-379, 1999. (Pubitemid 29318137)
14. Chattopadhyay K and Banerjee KK: Unfolding of Vibrio cholerae hemolysin induces oligomerization of the toxin monomer. J Biol Chem 278: 38470-38475, 2003. (Pubitemid 37221741)
15. Karunasagar I, Rivera I, Joseph B, Kennedy B, Shetty VR, Huq A, Karunasagar I and Colwell RR: ompU genes in non-toxigenic Vibrio cholerae associated with aquaculture. J Appl Microbiol 95: 338-343, 2003. (Pubitemid 36960396)
16. Olivier V, Haines GK III, Tan Y and Satchell KJ: Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains. Infect Immun 75: 5035-5042, 2007. (Pubitemid 47502177)
17. Liang W, Wang S, Yu F, Zhang L, Qi G, Liu Y, Gao S and Kan B: Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Infect Immun 71: 5498-5504, 2003. (Pubitemid 37205600)
18. Spangler BD: Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56: 622-647, 1992.
19. Pearson GD, Woods A, Chiang SL and Mekalanos JJ: CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc Natl Acad Sci USA 90: 3750-3754, 1993. (Pubitemid 23111445)
20. Kimsey HH and Waldor MK: CTXphi immunity: application in the development of cholera vaccines. Proc Natl Acad Sci USA 95: 7035-7039, 1998. (Pubitemid 28278102)
21. Yan M, Liu G, Diao B, Qiu H, Zhang L, Liang W, Gao S and Kan B: A Vibrio cholerae serogroup O1 vaccine candidate against CTX ET Phi infection. Vaccine 25: 4046-4055, 2007. (Pubitemid 46628986)
22. Ledón T, Ferrán B, Pérez C, Suzarte E, Vichi J, Marrero K, Oliva R and Fando R: TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera. Microbes Infect 14: 968-978, 2012.